Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:51 PM
Ignite Modification Date:
2025-12-24 @ 11:51 PM
NCT ID:
NCT01598051
Eligibility Criteria:
Inclusion Criteria:
* Patients treated by Warfarin for their atrial fibrillation for at least two months at the time of the study initiation.
* Rivaroxaban naïve patients
* Patients 20 years old or older.
* Patients who agree to sign the inform consent
Exclusion Criteria:
* Patients who are contraindicated by product label
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT01598051
Study Brief:
Protocol Section:
NCT01598051